| ARTICLE |
|
|
|
|
|
| Year : 2003 | Volume
: 45
| Issue : 1 | Page : 30-35 |
Risk Factors in Neuroleptic Malignant Syndrome
Vinay Gupta1, Rakesh Magon2, BP Mishra3, G.B.S Sidhu4, Ranjiv Mahajan1
1 Reader, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
2 Resident. Department of Psychiatry, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
3 Resident, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
4 Reader in clinical Psychology, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
Correspondence Address:
Vinay Gupta
Reader, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab
India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21206810 
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.
[PDF]*
|
